The Cannabis industry has gone through some changes during the last few months, shaping, step by step, the way in which we understand the use of medical cannabis and fighting against the remaining prejudice towards this natural alternative. From new scientific discoveries to the patients’ necessity to access this alternative treatment, governments have seen themselves [...]
During the last year 2018, the legislation surrounding therapeutic Cannabis in the UK was in constant change, due to the need to help patients suffering from severe intractable epilepsy. Besides, Canada became the second country worldwide, after Uruguay, to legalise medical cannabis programs. What has triggered the legal modifications in the UK? The British online [...]
According to the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition), Obsessive – Compulsive Disorder (OCD) is a mental disorder marked by anxiety or distress and characterized by the presence of persistent thoughts (obsessions). These recurrent thoughts are suppressed by new thoughts or actions (compulsions), which are acts performed in response to the [...]
On Thursday 27th of September, Epidiolex became the first cannabidiol-based substance placed under Schedule V of the Controlled Substances Act (CSA) by the Department of Justice and Drug Enforcement Administration (DEA). This was the consequence of a large, controlled and successful clinical trial that led the DEA to accept the medical application of this CBD-based [...]
